Tumour Virus Research : Impact Factor & More
eISSN: 2666-6790pISSN: 2666-6790
Open AccessShare this on:
Key Metrics
CiteScore 
8.3
SJR
Q2Virology
SNIP
1.44
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Tumour Virus Research
Tumour Virus Research Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 900 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Tumour Virus Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Tumour Virus Research
HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL
- 20 Jul 2026
- Tumour Virus Research
HPV8-E6 drives coordinated transcriptional and epigenetic reprogramming of keratinocytes.
- 13 Jul 2026
- Tumour virus research
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat.
- 27 Jun 2026
- Tumour virus research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL
- 20 Jul 2026
- Tumour Virus Research
HPV8-E6 drives coordinated transcriptional and epigenetic reprogramming of keratinocytes.
- 13 Jul 2026
- Tumour virus research
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat.
- 27 Jun 2026
- Tumour virus research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
FAQs on Tumour Virus Research
What is the publishing frequency of Tumour Virus Research? 
How many articles did Tumour Virus Research publish last year?
What is the eISSN & pISSN for Tumour Virus Research?
What is Citescore for Tumour Virus Research?
What is SNIP score for Tumour Virus Research?
What is the SJR for Tumour Virus Research?
Who is the publisher of Tumour Virus Research?
